{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:19:10Z","timestamp":1788304750574,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer US","isbn-type":[{"value":"9781071653678","type":"print"},{"value":"9781071653685","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5368-5_18","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:12:17Z","timestamp":1788304337000},"page":"309-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbohydrate Ligand-Mediated Precise Kidney Delivery of PNA"],"prefix":"10.1007","author":[{"given":"Vikas","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angana","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Bahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115073","volume":"201","author":"JW Lee","year":"2023","unstructured":"Lee JW, Shim MK, Kim H, Jang H, Lee Y, Kim SH (2023) RNAi therapies: expanding applications for extrahepatic diseases and overcoming delivery challenges. Adv Drug Deliv Rev 201:115073","journal-title":"Adv Drug Deliv Rev"},{"issue":"49","key":"18_CR2","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/ja505986a","volume":"136","author":"JK Nair","year":"2014","unstructured":"Nair JK, Willoughby JL, Chan A, Charisse K, Alam MR, Wang Q et al (2014) Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J Am Chem Soc 136(49):16958\u201316961","journal-title":"J Am Chem Soc"},{"issue":"1","key":"18_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41467-022-35637-z","volume":"14","author":"X Han","year":"2023","unstructured":"Han X, Gong N, Xue L, Billingsley MM, El-Mayta R, Shepherd SJ et al (2023) Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis. Nat Commun 14(1):75","journal-title":"Nat Commun"},{"issue":"7","key":"18_CR4","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1021\/acsnano.2c12140","volume":"17","author":"N Trac","year":"2023","unstructured":"Trac N, Ashraf A, Giblin J, Prakash S, Mitragotri S, Chung EJ (2023) Spotlight on genetic kidney diseases: a call for drug delivery and nanomedicine solutions. ACS Nano 17(7):6165\u20136177","journal-title":"ACS Nano"},{"issue":"12","key":"18_CR5","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1016\/j.ymthe.2024.10.020","volume":"32","author":"V Kumar","year":"2024","unstructured":"Kumar V, Wahane A, Tham MS, Somlo S, Gupta A, Bahal R (2024) Efficient and selective kidney targeting by chemically modified carbohydrate conjugates. Mol Ther 32(12):4383\u20134400","journal-title":"Mol Ther"},{"issue":"5037","key":"18_CR6","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1962210","volume":"254","author":"PE Nielsen","year":"1991","unstructured":"Nielsen PE, Egholm M, Berg RH, Buchardt O (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254(5037):1497\u20131500","journal-title":"Science"},{"issue":"1","key":"18_CR7","doi-asserted-by":"publisher","first-page":"101354","DOI":"10.1016\/j.xcrm.2023.101354","volume":"5","author":"S Malik","year":"2024","unstructured":"Malik S, Pradeep SP, Kumar V, Xiao Y, Deng Y, Fan R et al (2024) Antitumor efficacy of a sequence-specific DNA-targeted \u03b3PNA-based inhibitor. Cell Rep Med 5(1):101354","journal-title":"Cell Rep Med"},{"issue":"8","key":"18_CR8","doi-asserted-by":"publisher","first-page":"102120","DOI":"10.1016\/j.xcrp.2024.102120","volume":"5","author":"SP Pradeep","year":"2024","unstructured":"Pradeep SP, Kumar V, Malik S, Slack FJ, Gupta A, Bahal R (2024) Enhancing RNA inhibitory activity using clamp-G-modified nucleobases. Cell Rep Phys Sci 5(8):102120","journal-title":"Cell Rep Phys Sci"},{"issue":"22","key":"18_CR9","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1158\/0008-5472.CAN-21-0736","volume":"81","author":"K Dhuri","year":"2021","unstructured":"Dhuri K, Gaddam RR, Vikram A, Slack FJ, Bahal R (2021) Therapeutic potential of chemically modified, synthetic, triplex peptide nucleic acid\u2013based oncomir inhibitors for cancer therapy. Cancer Res 81(22):5613\u20135624","journal-title":"Cancer Res"},{"issue":"1","key":"18_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","volume":"9","author":"X Sun","year":"2024","unstructured":"Sun X, Setrerrahmane S, Li C, Hu J, Xu H (2024) Nucleic acid drugs: recent progress and future perspectives. Sig Transduct Target Ther 9(1):316","journal-title":"Sig Transduct Target Ther"},{"issue":"5","key":"18_CR11","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1021\/acsptsci.4c00106","volume":"7","author":"K Westerlund","year":"2024","unstructured":"Westerlund K, Oroujeni M, Gestin M, Clinton J, Hani Rosly A, Tano H et al (2024) Shorter peptide nucleic acid probes improve affibody-mediated peptide nucleic acid-based pretargeting. ACS Pharmacol Transl Sci 7(5):1595\u20131611","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"10","key":"18_CR12","doi-asserted-by":"publisher","first-page":"101584","DOI":"10.1016\/j.xcrp.2023.101584","volume":"4","author":"K Dhuri","year":"2023","unstructured":"Dhuri K, Duran T, Chaudhuri B, Slack FJ, Vikram A, Glazer PM et al (2023) Head-to-head comparison of in vitro and in vivo efficacy of pHLIP-conjugated anti-seed gamma peptide nucleic acids. Cell Rep Phys Sci 4(10):101584","journal-title":"Cell Rep Phys Sci"},{"issue":"12","key":"18_CR13","doi-asserted-by":"publisher","first-page":"2202859","DOI":"10.1002\/adhm.202202859","volume":"12","author":"V Kumar","year":"2023","unstructured":"Kumar V, Wahane A, Gupta A, Manautou JE, Bahal R (2023) Multivalent lactobionic acid and N-acetylgalactosamine-conjugated peptide nucleic acids for efficient in vivo targeting of hepatocytes. Adv Healthc Mater 12(12):2202859","journal-title":"Adv Healthc Mater"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3389\/fmicb.2019.01032","volume":"10","author":"L Goltermann","year":"2019","unstructured":"Goltermann L, Yavari N, Zhang M, Ghosal A, Nielsen PE (2019) PNA length restriction of antibacterial activity of peptide-PNA conjugates in Escherichia coli through effects of the inner membrane. Front Microbiol 10:1032","journal-title":"Front Microbiol"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","volume":"39","author":"S Ljungman","year":"1990","unstructured":"Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure: relationship of cardiac index to kidney function. Drugs 39:10\u201321","journal-title":"Drugs"},{"issue":"1","key":"18_CR16","doi-asserted-by":"publisher","first-page":"11550","DOI":"10.1038\/ncomms11550","volume":"7","author":"AE Perez Bay","year":"2016","unstructured":"Perez Bay AE, Schreiner R, Benedicto I, Paz Marzolo M, Banfelder J, Weinstein AM et al (2016) The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells. Nat Commun 7(1):11550","journal-title":"Nat Commun"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","volume":"84","author":"MS Balzer","year":"2022","unstructured":"Balzer MS, Rohacs T, Susztak K (2022) How many cell types are in the kidney and what do they do? Annu Rev Physiol 84:507\u2013531","journal-title":"Annu Rev Physiol"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/j.2040-4603.2013.tb00514.x","volume":"3","author":"JL Zhuo","year":"2013","unstructured":"Zhuo JL, Li XC (2013) Proximal nephron comprehensive physiology. Compr Physiol 3:1079\u20131123","journal-title":"Compr Physiol"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"e078242","DOI":"10.1136\/bmj-2023-078242","volume":"385","author":"N Simms-Williams","year":"2024","unstructured":"Simms-Williams N, Treves N, Yin H, Lu S, Yu O, Pradhan R et al (2024) Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ 385:e078242","journal-title":"BMJ"},{"issue":"9","key":"18_CR20","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1021\/acs.molpharmaceut.1c00511","volume":"18","author":"D Liu","year":"2021","unstructured":"Liu D, Du Y, Jin F-Y, Xu X-L, Du Y-Z (2021) Renal cell-targeted drug delivery strategy for acute kidney injury and chronic kidney disease: a mini-review. Mol Pharm 18(9):3206\u20133222","journal-title":"Mol Pharm"},{"issue":"1","key":"18_CR21","doi-asserted-by":"publisher","first-page":"26072","DOI":"10.1038\/srep26072","volume":"6","author":"L Wu","year":"2016","unstructured":"Wu L, Wang Q, Guo F, Ma X, Ji H, Liu F et al (2016) MicroRNA-27a induces mesangial cell injury by targeting of PPAR\u03b3 and its in vivo knockdown prevents progression of diabetic nephropathy. Sci Rep 6(1):26072","journal-title":"Sci Rep"},{"issue":"121","key":"18_CR22","doi-asserted-by":"publisher","first-page":"121ra18","DOI":"10.1126\/scitranslmed.3003205","volume":"4","author":"BN Chau","year":"2012","unstructured":"Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G et al (2012) MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 4(121):121ra18","journal-title":"Sci Transl Med"},{"issue":"1","key":"18_CR23","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1038\/s41467-019-11918-y","volume":"10","author":"EC Lee","year":"2019","unstructured":"Lee EC, Valencia T, Allerson C, Schairer A, Flaten A, Yheskel M et al (2019) Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease. Nat Commun 10(1):4148","journal-title":"Nat Commun"},{"issue":"22","key":"18_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131102","volume":"4","author":"NL Price","year":"2019","unstructured":"Price NL, Miguel V, Ding W, Singh AK, Malik S, Rotllan N et al (2019) Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis. JCI Insight 4(22):e131102","journal-title":"JCI Insight"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jconrel.2018.11.019","volume":"293","author":"H Shi","year":"2019","unstructured":"Shi H, Leonhard WN, Sijbrandi NJ, van Steenbergen MJ, Fens MH, van de Dikkenberg JB et al (2019) Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys. J Control Release 293:113\u2013125","journal-title":"J Control Release"},{"key":"18_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2020.101115","volume":"7","author":"S Malik","year":"2020","unstructured":"Malik S, Slack FJ, Bahal R (2020) Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids. MethodsX 7:101115","journal-title":"MethodsX"},{"issue":"6","key":"18_CR27","doi-asserted-by":"publisher","first-page":"F1141","DOI":"10.1152\/ajprenal.00344.2016","volume":"312","author":"RH Church","year":"2017","unstructured":"Church RH, Ali I, Tate M, Lavin D, Krishnakumar A, Kok HM et al (2017) Gremlin1 plays a key role in kidney development and renal fibrosis. Am J Physiol Ren Physiol 312(6):F1141\u2013F1F57","journal-title":"Am J Physiol Ren Physiol"}],"container-title":["Methods in Molecular Biology","Peptide Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5368-5_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:12:17Z","timestamp":1788304337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5368-5_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653678","9781071653685"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5368-5_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}